Search

everythinglearnresearchcommunity

for

Search:↓

Corni Fructus extract may help manage benign prostatic hyperplasia by reducing prostate cell growth and inflammation.

A newborn girl had a rare case of salivary gland tissue on her chest, which was safely removed.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Chemotherapy and radiotherapy improved quality of life and reduced symptoms in lung cancer patients.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Lichen planus commonly affects middle-aged adults, often involves limbs and mucosal areas, and can be linked to immune diseases.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

PRP injections are safe for hair loss treatment, but monitoring and sun protection are advised.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Megavoltage radiation therapy extended survival in rabbits with thymomas, especially in those weighing more than 1.57 kg.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.